Massage Therapy for Osteoarthritis of the Knee: A Randomized Dose-Finding Trial

作者
Adam Perlman,Ather Ali,Valentine Njike,David L. Hom,Anna Davidi,Susan Gould-Fogerite,Carl Milak,David L. Katz
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:7 (2): e30248-e30248 被引量:119
标识
DOI:10.1371/journal.pone.0030248
摘要

BACKGROUND: In a previous trial of massage for osteoarthritis (OA) of the knee, we demonstrated feasibility, safety and possible efficacy, with benefits that persisted at least 8 weeks beyond treatment termination. METHODS: We performed a RCT to identify the optimal dose of massage within an 8-week treatment regimen and to further examine durability of response. Participants were 125 adults with OA of the knee, randomized to one of four 8-week regimens of a standardized Swedish massage regimen (30 or 60 min weekly or biweekly) or to a Usual Care control. Outcomes included the Western Ontario and McMaster Universities Arthritis Index (WOMAC), visual analog pain scale, range of motion, and time to walk 50 feet, assessed at baseline, 8-, 16-, and 24-weeks. RESULTS: WOMAC Global scores improved significantly (24.0 points, 95% CI ranged from 15.3-32.7) in the 60-minute massage groups compared to Usual Care (6.3 points, 95% CI 0.1-12.8) at the primary endpoint of 8-weeks. WOMAC subscales of pain and functionality, as well as the visual analog pain scale also demonstrated significant improvements in the 60-minute doses compared to usual care. No significant differences were seen in range of motion at 8-weeks, and no significant effects were seen in any outcome measure at 24-weeks compared to usual care. A dose-response curve based on WOMAC Global scores shows increasing effect with greater total time of massage, but with a plateau at the 60-minute/week dose. CONCLUSION: Given the superior convenience of a once-weekly protocol, cost savings, and consistency with a typical real-world massage protocol, the 60-minute once weekly dose was determined to be optimal, establishing a standard for future trials. TRIAL REGISTRATION: ClinicalTrials.gov NCT00970008.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11完成签到 ,获得积分10
刚刚
张述杰完成签到,获得积分10
刚刚
change完成签到 ,获得积分10
1秒前
晴qq发布了新的文献求助10
1秒前
2秒前
kiki完成签到,获得积分10
2秒前
yolo完成签到,获得积分10
2秒前
yqcj59完成签到,获得积分10
3秒前
CC完成签到,获得积分10
3秒前
昵昵昵昵昵完成签到 ,获得积分10
3秒前
canghong完成签到,获得积分10
4秒前
Big胆完成签到,获得积分10
4秒前
星芒发布了新的文献求助10
5秒前
超级大电影完成签到,获得积分10
5秒前
亮倪力完成签到,获得积分10
5秒前
Rocc完成签到,获得积分10
5秒前
zxd完成签到,获得积分10
6秒前
Destiny完成签到,获得积分10
6秒前
zl02完成签到,获得积分10
7秒前
牟若溪发布了新的文献求助10
7秒前
yuyanqiao完成签到,获得积分10
8秒前
鲤鱼青雪完成签到,获得积分10
8秒前
9秒前
9秒前
华仔应助科研通管家采纳,获得30
9秒前
英姑应助科研通管家采纳,获得10
9秒前
ZAWJ完成签到,获得积分20
9秒前
窗窗窗雨完成签到,获得积分10
9秒前
搜集达人应助科研通管家采纳,获得10
9秒前
ding应助科研通管家采纳,获得10
9秒前
Hello应助科研通管家采纳,获得10
9秒前
搜集达人应助科研通管家采纳,获得10
9秒前
9秒前
深情安青应助科研通管家采纳,获得10
9秒前
9秒前
bkagyin应助科研通管家采纳,获得10
9秒前
Jasper应助科研通管家采纳,获得10
10秒前
小马甲应助科研通管家采纳,获得10
10秒前
充电宝应助科研通管家采纳,获得10
10秒前
打打应助科研通管家采纳,获得10
10秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7298539
求助须知:如何正确求助?哪些是违规求助? 8916989
关于积分的说明 18880573
捐赠科研通 6963638
什么是DOI,文献DOI怎么找? 3210680
关于科研通互助平台的介绍 2380000
邀请新用户注册赠送积分活动 2187188